Effects of Sirolimus on disease progression in patients with Autosomal Dominant Polycystic Kidney Disease and severe renal insufficiency - SIRENA II Effects of Sirolimus on disease progression in patients with Autosomal Dominant Polycystic Kidney Di ...
Effects of Sirolimus on disease progression in patients with Autosomal Dominant Polycystic Kidney Disease and severe renal insufficiency - SIRENA II Effects of Sirolimus on disease progression in patients with Autosomal Dominant Polycystic Kidney Di ...
Trade Name: RAPAMUNE*100CPRRIV1MG INN or Proposed INN: Sirolimus Trade Name: RAPAMUNE*30CPR RIV 2MG INN or Proposed INN: Sirolimus Trade Name: RAPAMUNE*100CPRRIV1MG INN or Proposed INN: Sirolimus Trade Name: RAPAMUNE*30CPR RIV2MG IN ...
RAPAMYCIN FOR TREATMENT OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE - RAPYD-STUDY
RAPAMYCIN FOR TREATMENT OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE - RAPYD-STUDY
ADPKD type I MedDRA version: 9.1;Level: SOC;Classification code 10038359;Term: Renal and urinary disorders ADPKD type I MedDRA version: 9.1;Level: SOC;Classification code 10038359;Term: Renal and urinary dis ...
Trade Name: RAPAMUNE*100CPRRIV1MG INN or Proposed INN: Sirolimus Product Name: Ramipril INN or Proposed INN: Ramipril Trade Name: RAPAMUNE*100CPRRIV1MG INN or Proposed INN: Sirolimus Product Name: Ramipril INN or Propos ...